Sign In
Buy ATER
$0.410
+0.0201 (+5.15%)
At Close: Jul 31, 2026
Aterian, Inc. (ATER) Q2 2024 Earnings Call Transcript
01:55pm, Friday, 09'th Aug 2024
Aterian, Inc. (NASDAQ:ATER ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, Investor Relations & Corporate Development Arturo Rodrigue
Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference Call
10:30am, Monday, 29'th Jul 2024
SUMMIT, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its second quarter 2024 financial results after the market close on
Aterian: Cheap, But Speculative Turnaround Play - Upgrade To Buy
08:55am, Thursday, 27'th Jun 2024
After the close of Wednesday's regular session, e-commerce brand consolidator Aterian raised Q2 expectations for botth the top- and bottom line. Following years of revenue declines and material cash b
Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
04:30pm, Wednesday, 26'th Jun 2024
Arturo Rodriguez Appointed CEO Josh Feldman Appointed CFO Second Quarter 2024 Net Revenue Range Improved to Between $23 Million to $26 Million Second Quarter 2024 Adjusted EBITDA Range Improved to Bet
Aterian Investment Partners Acquires Contract Pharmaceuticals Limited
09:00am, Thursday, 06'th Jun 2024
NEW YORK & MIAMI--(BUSINESS WIRE)--Aterian Investment Partners (“Aterian”), a private investment firm, is pleased to announce that one of its affiliates has closed its acquisition of Contract Phar
Aterian, Inc. (ATER) Q1 2024 Earnings Call Transcript
08:18pm, Tuesday, 07'th May 2024
Aterian, Inc. (NASDAQ:ATER ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, IR & Corporate Development Joseph Risico - Co-CEO Arturo Rodr
Aterian Reports First Quarter 2024 Results
04:15pm, Tuesday, 07'th May 2024
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE)
Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call
06:37pm, Thursday, 25'th Apr 2024
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2024 financial results after the market close on Tue
Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA Ranges
07:30am, Monday, 22'nd Apr 2024
First Quarter Net Revenue Range Improved to $20.0 Million to $21.0 Million First Quarter Adjusted EBITDA Loss Range Improved to ($2.4) Million to ($2.9) Million NEW YORK, April 22, 2024 (GLOBE NEWSWIR
Aterian Announces Reverse Stock Split
07:46am, Wednesday, 20'th Mar 2024
NEW YORK, March 20, 2024 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) has announced a 1-for-12 reverse stock split of its common stock, effective with the mar
Aterian Announces Reverse Stock Split
07:30am, Wednesday, 20'th Mar 2024
Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024 Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024
Aterian, Inc. (ATER) Q4 2023 Earnings Call Transcript
09:30pm, Tuesday, 12'th Mar 2024
Aterian, Inc. (ATER) Q4 2023 Earnings Call Transcript
Aterian Reports Fourth Quarter & Full Year 2023 Results
04:15pm, Tuesday, 12'th Mar 2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2023. F
Aterian Makes Strategic Minority Equity Investment in 4th & Heart
04:30pm, Thursday, 07'th Mar 2024
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Hea
Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call
04:30pm, Thursday, 29'th Feb 2024
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its fourth quarter and full year 2023 financial results after the marke
